Leadership Overview
Novartis has 10 executives leading key functions including finance, information technology, and country leadership.
Driven by a commitment to innovation, Novartis is dedicated to reimagining medicine to improve and extend people's lives. The company's leadership philosophy centers on scientific advancement and global patient access, impacting healthcare worldwide.
Driven by a commitment to innovation, Novartis is dedicated to reimagining medicine to improve and extend people's lives. The company's leadership philosophy centers on scientific advancement and global patient access, impacting healthcare worldwide.
Leadership Roles at Novartis
Sylvester Feddes - Country President & Chief Executive Officer (Brazil)
Sylvester Feddes, the Country President & Chief Executive Officer (Brazil) at Novartis, directs the company's comprehensive operations and strategic vision within Brazil. This executive leadership position involves overseeing all business functions, from pharmaceutical development and commercialization to market access and patient engagement. Feddes's responsibilities include driving market growth, ensuring regulatory compliance, and fostering strong relationships with healthcare stakeholders across the country. By leading strategic initiatives, Sylvester Feddes champions Novartis's commitment to delivering innovative medications and improving patient outcomes in Brazil. The Country President & Chief Executive Officer's role is paramount in executing the company's global mission at a national level.
Natalia Somova - Chief Financial Officer
Natalia Somova, the Chief Financial Officer at Novartis, directs the financial strategy and operations for the global pharmaceutical manufacturer. This leadership role involves overseeing all aspects of financial planning, analysis, and reporting, ensuring fiscal responsibility and driving sustainable growth. Somova's oversight extends to managing capital allocation, optimizing resource deployment, and maintaining strong relationships with investors and financial institutions. By ensuring robust financial controls and strategic investment decisions, Natalia Somova supports Novartis's mission to develop innovative medications and healthcare solutions across diverse therapeutic areas. The financial acumen provided by the Chief Financial Officer is critical for funding extensive research and development initiatives and maintaining a significant global presence.
Daley Sebastian - Group Chief Financial Officer, Novartis Gulf & Saudi Country
Daley Sebastian, the Group Chief Financial Officer, Novartis Gulf & Saudi Country at Novartis, spearheads financial operations and strategic planning for the Gulf and Saudi Arabian markets. This critical role involves managing regional financial performance, driving revenue growth, and ensuring compliance with local financial regulations. Sebastian's oversight includes budgeting, forecasting, and investment analysis, directly supporting Novartis's expansion and market penetration in these key territories. By providing astute financial leadership, Daley Sebastian enables the delivery of innovative medications and healthcare solutions tailored to regional needs. The Group Chief Financial Officer's expertise is vital for navigating complex market dynamics and maximizing financial impact across the specified countries.
Sean Cochran - Head Chief Financial Officer, Finance Navigate Biopharma
Sean Cochran, the Head Chief Financial Officer, Finance Navigate Biopharma at Novartis, directs the financial strategy and execution for the Navigate Biopharma division. This executive function encompasses managing all financial aspects of biopharmaceutical development, including funding research, optimizing operational expenditures, and ensuring profitability. Cochran's responsibilities involve close collaboration with R&D teams to align financial resources with scientific objectives, driving the successful commercialization of new treatments. By providing rigorous financial oversight and strategic guidance, Sean Cochran supports the advancement of groundbreaking therapies. The Head Chief Financial Officer's role is fundamental to the financial health and strategic direction of Novartis's biopharmaceutical ventures.
Emin Ertugrul - Ad-Interim Chief Financial Officer (Middle Trkiye Afrika, East)
Emin Ertugrul, the Ad-Interim Chief Financial Officer (Middle Trkiye Afrika, East) at Novartis, provides critical financial leadership across the Middle, Türkiye, Africa, and East regions. This executive role involves managing regional financial performance, overseeing budgeting and forecasting, and ensuring fiscal discipline to support Novartis's healthcare solutions. Ertugrul's focus includes optimizing financial operations, driving revenue generation, and navigating the unique economic landscapes of these diverse markets. By delivering strategic financial insights, Emin Ertugrul facilitates the company's mission to improve patient outcomes through innovative medications. The Ad-Interim Chief Financial Officer's adaptable leadership is essential for sustained growth and operational excellence in these expansive territories.
Mita Ganatra - Head Chief Financial Officer, Novartis Corporate Center Hyderabad & Finance Infrastructure Investments
Mita Ganatra, the Head Chief Financial Officer, Novartis Corporate Center Hyderabad & Finance Infrastructure Investments at Novartis, leads financial operations and investment strategies for the Hyderabad Corporate Center and infrastructure projects. This executive function involves managing financial planning, budgeting, and reporting, ensuring fiscal prudence and strategic resource allocation. Ganatra's oversight extends to evaluating and executing infrastructure investments that support Novartis's global operational capabilities. By providing expert financial guidance, Mita Ganatra contributes to the efficient functioning of the Hyderabad center and the successful development of critical infrastructure. The Head Chief Financial Officer's financial acumen is vital for optimizing investments and supporting long-term company objectives.
Christine NielsenDOrsi - Chief Financial Officer, Country Chile
Christine NielsenDOrsi, the Chief Financial Officer, Country Chile at Novartis, manages the financial strategy and operations for the Chilean market. This key executive role involves overseeing financial planning, analysis, and reporting, ensuring fiscal health and driving sustainable business growth within the country. NielsenDOrsi's responsibilities include optimizing financial performance, managing budgets, and supporting strategic investments that align with Novartis's mission to provide innovative healthcare solutions. By delivering robust financial leadership, Christine NielsenDOrsi enables the effective delivery of medications and treatments to patients in Chile. The Chief Financial Officer's financial expertise is crucial for navigating the local economic landscape and achieving corporate objectives.
Daniel Stevens - Chief Information Officer
Daniel Stevens, the Chief Information Officer at Novartis, architects the company's global technology strategy and digital transformation initiatives. This executive position involves leading the IT infrastructure, cybersecurity, and data management functions, ensuring seamless operations and secure data handling across all regions. Stevens's responsibilities include driving innovation through technology adoption, enhancing operational efficiency via digital tools, and supporting the company's research and development efforts with advanced data analytics capabilities. By implementing cutting-edge IT solutions, Daniel Stevens empowers Novartis to accelerate the development of novel treatments and improve patient outcomes worldwide. The Chief Information Officer's strategic vision is essential for maintaining Novartis's competitive edge in the pharmaceutical industry.
Dipshikha Das - Director, Medical Strategy Execution (Chief of Staff), US Evidence Generation
Dipshikha Das, the Director, Medical Strategy Execution (Chief of Staff), US Evidence Generation at Novartis, orchestrates the strategic implementation of medical evidence generation initiatives within the United States. This pivotal role involves aligning medical strategy with operational execution, ensuring that research and data collection efforts effectively support the development and approval of innovative treatments. Das's responsibilities include managing cross-functional collaboration, optimizing project timelines, and ensuring the rigorous scientific integrity of evidence generation processes. By driving strategic execution, Dipshikha Das enhances Novartis's ability to demonstrate the value and efficacy of its healthcare solutions. The Director's leadership is crucial for translating medical strategy into tangible outcomes that improve patient care.
Soukaïna Mouallif - Customer Engagement Chief of Staff (US)
Soukaïna Mouallif, the Customer Engagement Chief of Staff (US) at Novartis, drives the strategic execution of customer engagement initiatives across the United States. This executive position involves enhancing customer experience through coordinated efforts, ensuring seamless interaction with healthcare professionals and patient communities. Mouallif's responsibilities include optimizing engagement strategies, managing cross-functional alignment, and implementing innovative approaches to build stronger customer relationships. By leading strategic initiatives, Soukaïna Mouallif supports Novartis's commitment to improving patient outcomes and delivering value through its healthcare solutions. The Chief of Staff's role is instrumental in translating engagement strategies into impactful customer interactions.
Explore Leadership Teams in Manufacturing
Lonza is a global supplier serving the pharmaceutical, biotech, and specialty ingredients markets. The company provides a broad portfolio of services and products, including active pharmaceutical ingredients, drinking water sanitizers, nutritional and personal care ingredients, agricultural solutions, industrial preservatives, and microbial control technologies that address harmful viruses, bacteria, and other pathogens. Founded in the Swiss Alps, Lonza operates through two primary market-focused segments — Pharma & Biotech and Specialty Ingredients — reflecting its commitment to innovation and global health advancement.
Company Leadership JO
RW
MM
Sentiss Pharma is a niche pharmaceutical company that specializes in providing high-quality ophthalmic, inhalation, otic, and nasal drop products. Established in 1990, the company is dedicated to delivering innovative healthcare solutions globally while maintaining a strong commitment to quality and social responsibility. Their product portfolio includes a range of specialty products aimed at improving health outcomes. Sentiss is recognized as a Great Place to Work in India for nine consecutive years, reflecting its focus on employee satisfaction and community engagement.
Company Leadership DB
SO
Chemipharm is the only company selling directly to 100% of the reachable pharmacies and hospitals in Egypt. Chemipharm's distribution network includes: 12 branches allover Egypt. 100 fixed routes every day. Total 150 visiting all the pharmacies all over the country. Latest News : PROFILE Company Profile: Chemipharm was founded in 1972 by Dr. Gamal Kamel as the first private sector importer of pharmaceutical products in Egypt. Over the last 35 years, Chemipharm has developed and maintained an invaluable reputation as Egypt's most respectable and high standards pharmaceutical distributor. In 2003, based on the company's continuous growth, Chemipharm has established its own manufacturing facility in the 6th of October Industrial Zone. Plant was designed by Pharma Consult. The modern GMP plant produces pharmaceutical products of all major forms (tablets, capsules, syrups and ointments). Presently Chemipharm is constructing a new sterile area to produce ampoules, eye drops and antibiotics. The company's strategy is based on continuous improvement and growth.
Company Leadership KK
DO
NM
Eurofarma is a pharmaceutical company that offers a diverse range of products including prescription medications, generics, oncology treatments, hospital care products, personal care items, and nutritional supplements. Their services are aimed at healthcare professionals, consumers, pharmacies, and B2B clients across various countries in Latin America. The company is committed to sustainability and innovation, actively engaging in clinical research and development. With over 50 years in the industry, Eurofarma focuses on improving health and wellness while maintaining a strong corporate governance framework.
Company Leadership MB
ET
FD
BS
Frequently Asked Questions Regarding Novartis Top Executives and Leadership Team
